Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra E Irvine

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Journal of Cell Communication and Signaling|February 26, 2015
The NOTCH signaling pathway in normal and malignant blood cell productionSukanya Suresh, Alexandra E Irvine
Methods in Molecular Biology (Clifton, N.J.)|October 14, 2016
Separation and Enrichment of Hematopoietic Stem Cells for CCN StudiesLisa J Crawford, Alexandra E Irvine
Blood Reviews|November 5, 2013
Targeting the ubiquitin proteasome system in haematological malignanciesLisa J Crawford, Alexandra E Irvine
Hematology (Amsterdam, Netherlands)|October 8, 2003
The proteasome: a novel therapeutic target in haematopoietic malignancyLaura Magill, Brian Walker, Alexandra E Irvine
Journal of Cell Communication and Signaling|April 17, 2009
A rapid and sensitive method for measuring cell adhesionWanhua Lu, Lynn McCallum, Alexandra E Irvine
Journal of Cell Communication and Signaling|April 13, 2011
Proteasome inhibitors in cancer therapyLisa J Crawford, Brian Walker, Alexandra E Irvine
Journal of Cell Communication and Signaling|November 8, 2017
TRIM proteins in blood cancersLisa J Crawford, Cliona K Johnston, Alexandra E Irvine
Oncotarget|September 23, 2016
Identification of the APC/C co-factor FZR1 as a novel therapeutic target for multiple myelomaLisa J Crawford, Gordon Anderson, Cliona K Johnston, et al.
Hematological Oncology|March 8, 2008
The therapeutic potential of the proteasome in leukaemiaScott Marshall McCloskey, Mary Frances McMullin, Brian Walker, et al.
Haematologica|December 14, 2004
Proteasome proteolytic activity in hematopoietic cells from patients with chronic myeloid leukemia and multiple myelomaLaura Magill, John Lynas, Trenn C M Morris, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Journal of Cell Communication and Signaling|February 26, 2015
The NOTCH signaling pathway in normal and malignant blood cell productionSukanya Suresh, Alexandra E Irvine
Methods in Molecular Biology (Clifton, N.J.)|October 14, 2016
Separation and Enrichment of Hematopoietic Stem Cells for CCN StudiesLisa J Crawford, Alexandra E Irvine
Blood Reviews|November 5, 2013
Targeting the ubiquitin proteasome system in haematological malignanciesLisa J Crawford, Alexandra E Irvine
Hematology (Amsterdam, Netherlands)|October 8, 2003
The proteasome: a novel therapeutic target in haematopoietic malignancyLaura Magill, Brian Walker, Alexandra E Irvine
Journal of Cell Communication and Signaling|April 17, 2009
A rapid and sensitive method for measuring cell adhesionWanhua Lu, Lynn McCallum, Alexandra E Irvine
Journal of Cell Communication and Signaling|April 13, 2011
Proteasome inhibitors in cancer therapyLisa J Crawford, Brian Walker, Alexandra E Irvine
Journal of Cell Communication and Signaling|November 8, 2017
TRIM proteins in blood cancersLisa J Crawford, Cliona K Johnston, Alexandra E Irvine
Oncotarget|September 23, 2016
Identification of the APC/C co-factor FZR1 as a novel therapeutic target for multiple myelomaLisa J Crawford, Gordon Anderson, Cliona K Johnston, et al.
Hematological Oncology|March 8, 2008
The therapeutic potential of the proteasome in leukaemiaScott Marshall McCloskey, Mary Frances McMullin, Brian Walker, et al.
Haematologica|December 14, 2004
Proteasome proteolytic activity in hematopoietic cells from patients with chronic myeloid leukemia and multiple myelomaLaura Magill, John Lynas, Trenn C M Morris, et al.
Pageof 3